HK1000495A1 - Novel compound, process for producing the same, and antitumor agent - Google Patents
Novel compound, process for producing the same, and antitumor agentInfo
- Publication number
- HK1000495A1 HK1000495A1 HK97101948A HK97101948A HK1000495A1 HK 1000495 A1 HK1000495 A1 HK 1000495A1 HK 97101948 A HK97101948 A HK 97101948A HK 97101948 A HK97101948 A HK 97101948A HK 1000495 A1 HK1000495 A1 HK 1000495A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- hydrogen atom
- producing
- same
- group
- lower alkyl
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 239000002246 antineoplastic agent Substances 0.000 title abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 5
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- YSLIPUSJNFIFAB-UHFFFAOYSA-N 2-oxopyridine-1-carboxylic acid Chemical class OC(=O)N1C=CC=CC1=O YSLIPUSJNFIFAB-UHFFFAOYSA-N 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Pyridine Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP15657894 | 1994-06-14 | ||
JP19792194 | 1994-07-28 | ||
JP30691494 | 1994-11-15 | ||
JP33995694 | 1994-12-28 | ||
JP8170595 | 1995-03-13 | ||
PCT/JP1995/001110 WO1995034559A1 (fr) | 1994-06-14 | 1995-06-06 | Nouveau compose, son procede de production et agent antitumoral |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1000495A1 true HK1000495A1 (en) | 2002-07-19 |
Family
ID=27524935
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK97101948A HK1000495A1 (en) | 1994-06-14 | 1997-10-17 | Novel compound, process for producing the same, and antitumor agent |
Country Status (27)
Country | Link |
---|---|
US (1) | US5817669A (ru) |
EP (1) | EP0787726B1 (ru) |
JP (1) | JP3391796B2 (ru) |
KR (1) | KR100350921B1 (ru) |
CN (1) | CN1053668C (ru) |
AT (1) | ATE209645T1 (ru) |
AU (1) | AU679859B2 (ru) |
BR (1) | BR9508037A (ru) |
CA (1) | CA2192824C (ru) |
CZ (1) | CZ292631B6 (ru) |
DE (1) | DE69524251T2 (ru) |
DK (1) | DK0787726T3 (ru) |
ES (1) | ES2163512T3 (ru) |
FI (1) | FI112485B (ru) |
HK (1) | HK1000495A1 (ru) |
HU (1) | HU220072B (ru) |
MX (1) | MX9606331A (ru) |
NO (1) | NO307255B1 (ru) |
NZ (1) | NZ287139A (ru) |
PL (1) | PL181867B1 (ru) |
PT (1) | PT787726E (ru) |
RO (1) | RO117793B1 (ru) |
RU (1) | RU2151770C1 (ru) |
SI (1) | SI0787726T1 (ru) |
SK (1) | SK281341B6 (ru) |
TW (1) | TW319769B (ru) |
WO (1) | WO1995034559A1 (ru) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005504808A (ja) * | 2001-09-26 | 2005-02-17 | バイエル・フアーマシユーチカルズ・コーポレーシヨン | 抗糖尿病薬としての1,6−ナフチリジン誘導体 |
US6802423B2 (en) * | 2002-02-20 | 2004-10-12 | Trans Global Foods, Inc. | Disposable food delivery apparatus |
EP1610795A4 (en) * | 2003-04-07 | 2007-10-24 | Cylene Pharmaceuticals Inc | SUBSTITUTED 1,4-DIHYDRO-4-OXO-1,8-NAPHTHPYRIDINE HETEROCYCLIC ANALOGUES |
CN100410249C (zh) * | 2003-09-10 | 2008-08-13 | 杏林制药株式会社 | 7-(4-取代-3-环丙基氨基甲基-1-吡咯烷基)喹诺酮羧酸衍生物 |
DE10352979A1 (de) * | 2003-11-13 | 2005-06-09 | Merck Patent Gmbh | Pyridopyrimidinone |
JP5317472B2 (ja) * | 2004-03-15 | 2013-10-16 | サネシス ファーマシューティカルズ, インコーポレイテッド | Sns−595、及びその使用方法 |
AU2013201203C1 (en) * | 2004-03-15 | 2015-04-23 | Sumitomo Dainippon Pharma Co., Ltd. | Sns-595 and methods of using the same |
US7563805B2 (en) | 2005-05-19 | 2009-07-21 | Daiichi Pharmaceutical Co., Ltd. | Tri-, tetra-substituted-3-aminopyrrolidine derivative |
WO2007022474A2 (en) * | 2005-08-19 | 2007-02-22 | Cylene Pharmaceuticals, Inc. | HUMAN RIBOSOMAL DNA(rDNA) AND RIBOSOMAL RNA (rRNA) NUCLEIC ACIDS AND USES THEREOF |
US8580814B2 (en) * | 2006-04-03 | 2013-11-12 | Sunesis Pharmaceuticals, Inc. | Methods of using (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4- oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of cancer |
EP1931339B1 (en) * | 2005-09-02 | 2018-05-16 | Sunesis Pharmaceuticals, Inc. | Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of cancer |
AU2013219242C1 (en) * | 2005-09-02 | 2016-09-22 | Sunesis Pharmaceuticals, Inc. | Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of cancer |
KR20170118936A (ko) * | 2005-09-02 | 2017-10-25 | 선에시스 파마슈티컬스 인코포레이티드 | 암 치료를 위한 (+)-1,4-디히드로-7-[(3s,4s)-3-메톡시-4-(메틸아미노)-1-피롤리디닐]-4-옥소-1-(2-티아졸릴)-1,8-나프티리딘-3-카르복실산의 사용 방법 |
CN104873502A (zh) * | 2005-09-02 | 2015-09-02 | 逊尼希思制药公司 | 使用(+)-1,4-二氢-7-[(3s,4s)-3-甲氧基-4-(甲氨基)-1-吡咯烷基]-4-氧代-1-(2-噻唑基)-1,8-萘啶-3-羧酸治疗癌症的方法 |
TW200800983A (en) | 2005-09-14 | 2008-01-01 | Janssen Pharmaceutica Nv | 5-oxo-5,8-dihydro-pyrido-pyrimidines as inhibitors of C-FMS kinase |
BRPI0615838A2 (pt) * | 2005-09-14 | 2011-05-31 | Janssen Pharmaceutica Nv | 5-oxo-5,8-dihidro-pirido-pirimidinas como inibidores de ofc-fms cinase |
US7642270B2 (en) | 2005-09-14 | 2010-01-05 | Janssen Pharmaceutica N.V. | 5-oxo-5,8-dihydro-pyrido-pyrimidine as inhibitors of c-fms kinase |
JP2009539994A (ja) | 2006-06-12 | 2009-11-19 | サネシス ファーマシューティカルズ, インコーポレイテッド | 癌の治療のための化合物及び組成物 |
US20100048609A1 (en) * | 2006-08-01 | 2010-02-25 | Jacobs Jeffrey W | Pharmaceutical dosage forms for (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid |
ES2556677T3 (es) * | 2006-08-02 | 2016-01-19 | Sunesis Pharmaceuticals, Inc. | Utilización combinada de ácido (+)-1,4-dihidro-7-[(3S,4S)-3-metoxi-4-(metilamino)-1-pirrolidinil]-4-oxo-1-(2-tiazolil)-1,8-naftiridin-3-carboxílico y citarabina (Ara-C) para el tratamiento de la leucemia |
WO2009054935A1 (en) * | 2007-10-22 | 2009-04-30 | Sunesis Pharmaceuticals, Inc. | Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid in combination therapy |
EP2649997B1 (en) * | 2007-12-10 | 2019-01-23 | Sunesis Pharmaceuticals, Inc. | (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for use in the treatment of myelodyspastic syndrome |
KR101765956B1 (ko) | 2008-12-31 | 2017-08-07 | 선에시스 파마슈티컬스 인코포레이티드 | (+)-1,4-다이하이드로-7-[(3s,4s)-3-메톡시-4-(메틸아미노)-1-피롤리딘일]-4-옥소-1-(2-티아졸릴)-1,8-나프티리딘-3-카복실산의 제조 방법 |
JP5936862B2 (ja) | 2009-02-27 | 2016-06-22 | サネシス ファーマシューティカルズ, インコーポレイテッド | Brca2活性が低下した癌対象の治療のためのsns−595の使用方法 |
UA110465C2 (ru) * | 2009-09-04 | 2016-01-12 | Sunesis Pharmaceutecals Inc | Стабільна композиція sns-595 |
TW201120037A (en) * | 2009-10-26 | 2011-06-16 | Sunesis Pharmaceuticals Inc | Compounds and methods for treatment of cancer |
CN108329246B (zh) | 2011-05-13 | 2021-02-26 | 阵列生物制药公司 | 作为trka激酶抑制剂的吡咯烷基脲和吡咯烷基硫脲化合物 |
CN103497186B (zh) * | 2013-09-24 | 2015-02-25 | 浙江司太立制药股份有限公司 | 含有烷氧亚氨基取代的萘啶酮羧酸衍生物及其制备方法 |
JPWO2018174266A1 (ja) * | 2017-03-24 | 2020-01-30 | 湧永製薬株式会社 | 新規ピリドンカルボン酸誘導体又はその塩 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4730000A (en) * | 1984-04-09 | 1988-03-08 | Abbott Laboratories | Quinoline antibacterial compounds |
EP0154780B1 (en) * | 1984-01-26 | 1990-04-11 | Abbott Laboratories | Quinoline antibacterial compounds |
NZ210847A (en) * | 1984-01-26 | 1988-02-29 | Abbott Lab | Naphthyridine and pyridopyrimidine derivatives and pharmaceutical compositions |
JPS61152682A (ja) * | 1984-12-27 | 1986-07-11 | Dainippon Pharmaceut Co Ltd | ピリドンカルボン酸誘導体、そのエステルおよびその塩 |
JPS61251667A (ja) * | 1985-04-30 | 1986-11-08 | Otsuka Pharmaceut Co Ltd | ベンゾヘテロ環化合物 |
IE60420B1 (en) * | 1985-06-13 | 1994-07-13 | Schering Corp | Polycyclic quinoline, naphthyridine and pyrazinopyridine derivatives |
EP0226624A1 (en) * | 1985-06-14 | 1987-07-01 | The Upjohn Company | Cyclopentapyrazole and tetrahydroindazole compounds |
JPS6233176A (ja) * | 1985-08-05 | 1987-02-13 | Toyama Chem Co Ltd | 1,4−ジヒドロ−4−オキソナフチリジン誘導体およびその塩 |
JP2704428B2 (ja) * | 1988-06-15 | 1998-01-26 | 富山化学工業株式会社 | キノロンカルボン酸誘導体またはその塩 |
DE3906365A1 (de) * | 1988-07-15 | 1990-01-18 | Bayer Ag | 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe |
JPH06233176A (ja) * | 1993-01-29 | 1994-08-19 | Sony Corp | ビデオカメラ |
-
1995
- 1995-06-06 MX MX9606331A patent/MX9606331A/es unknown
- 1995-06-06 HU HU9603455A patent/HU220072B/hu unknown
- 1995-06-06 AU AU25767/95A patent/AU679859B2/en not_active Expired
- 1995-06-06 ES ES95920265T patent/ES2163512T3/es not_active Expired - Lifetime
- 1995-06-06 JP JP50192396A patent/JP3391796B2/ja not_active Expired - Lifetime
- 1995-06-06 PL PL95317726A patent/PL181867B1/pl unknown
- 1995-06-06 EP EP95920265A patent/EP0787726B1/en not_active Expired - Lifetime
- 1995-06-06 CZ CZ19963643A patent/CZ292631B6/cs not_active IP Right Cessation
- 1995-06-06 CN CN95194461A patent/CN1053668C/zh not_active Expired - Lifetime
- 1995-06-06 SK SK1574-96A patent/SK281341B6/sk not_active IP Right Cessation
- 1995-06-06 RU RU97100718/04A patent/RU2151770C1/ru active
- 1995-06-06 WO PCT/JP1995/001110 patent/WO1995034559A1/ja active IP Right Grant
- 1995-06-06 DK DK95920265T patent/DK0787726T3/da active
- 1995-06-06 CA CA002192824A patent/CA2192824C/en not_active Expired - Lifetime
- 1995-06-06 RO RO96-02349A patent/RO117793B1/ro unknown
- 1995-06-06 NZ NZ287139A patent/NZ287139A/en not_active IP Right Cessation
- 1995-06-06 US US08/765,232 patent/US5817669A/en not_active Expired - Lifetime
- 1995-06-06 SI SI9530567T patent/SI0787726T1/xx unknown
- 1995-06-06 DE DE69524251T patent/DE69524251T2/de not_active Expired - Lifetime
- 1995-06-06 KR KR1019960707029A patent/KR100350921B1/ko not_active IP Right Cessation
- 1995-06-06 BR BR9508037A patent/BR9508037A/pt not_active IP Right Cessation
- 1995-06-06 PT PT95920265T patent/PT787726E/pt unknown
- 1995-06-06 AT AT95920265T patent/ATE209645T1/de active
- 1995-06-13 TW TW084106000A patent/TW319769B/zh not_active IP Right Cessation
-
1996
- 1996-12-11 NO NO965305A patent/NO307255B1/no not_active IP Right Cessation
- 1996-12-13 FI FI965020A patent/FI112485B/fi not_active IP Right Cessation
-
1997
- 1997-10-17 HK HK97101948A patent/HK1000495A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU679859B2 (en) | Novel compound, process for producing the same, and antitumor agent | |
EP0945452A4 (en) | SUGAR COMPOSITIONS, GELLING AGENTS, GELLING AGENT COMPOSITIONS, METHODS OF PREPARING SAME, AND GEL COMPOSITIONS | |
ES8607287A1 (es) | Un procedimiento para preparar derivados de 1,8-naftiridina | |
HUT54685A (en) | Process for producing condensed heterocyclic compounds, salts and intermediates, and fungicide compositions containing them | |
ZA88309B (en) | 3(2h)pyridazinone,process for its preparation and antagonistic agent against srs-a containing it | |
HUT59378A (en) | Process for producing urea derivatives and pharmaceutical compositions comprising such compounds | |
UA41904C2 (ru) | Способ получения бензопирановых соединений, промежуточных соединений, способ получения промежуточных соединений | |
HUT47099A (en) | Process for producing pyridine derivatives and pharmaceutical compositions comprising such compounds | |
PH24176A (en) | New bicyclic compounds,process for preparation thereof and pharmaceutical composition comprising the same | |
AU7928791A (en) | Bisphophonic acid derivatives, their production and use | |
NZ222185A (en) | N-substituted methanesulphonamide derivatives, and anticancer compositions containing such | |
IN167606B (ru) | ||
AU1589695A (en) | Bicyclic amino group-substituted pyridonecarboxylic acid derivatives, esters thereof and salts thereof, and bicyclic amines useful as intermediates thereof | |
HUT59083A (en) | Improved process for producing 4-methyl-sulfonyl-benzoic acid derivatives | |
EP0971899A4 (en) | HEXAHYDROINDENOPYRIDINE COMPOUNDS WITH ANTISPERMATOGENIC ACTIVITY | |
ZA869742B (en) | Novel pregnane derivatives,processes for their preparation and pharmaceutical compositions containing same | |
ZA803682B (en) | Clavulanic acid derivatives, a process for their preparation and their use | |
HU906407D0 (en) | Process for producing new inozine- and guanozine derivatives and pharmaceutical compositions containing them as active components |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PF | Patent in force | ||
PE | Patent expired |
Effective date: 20150605 |